IMBDX

Service

Early detection of cancer.

Clinical Service

Patients with advanced solid tumors may be tested with AlphaLiquid® 100 after consulting with their primary care physician
at major general hospitals in Korea.

AlphaLiquid®100 Test
List of Available Hospitals

Type Hospital
In-house Testing
(also available at affiliated
hospitals via referral)
Seoul St. Mary’s Hospital, Catholic University of Korea
Daejeon St. Mary’s Hospital, Catholic University of Korea
St. Vincent’s Hospital, Catholic University of Korea
Yeouido St. Mary’s Hospital, Catholic University of Korea
Eunpyeong St. Mary’s Hospital, Catholic University of Korea
Uijeongbu St. Mary’s Hospital, Catholic University of Korea
Incheon St. Mary’s Hospital, Catholic University of Korea
Korea University Anam Hospital
Korea University Guro Hospital
Korea University Ansan Hospital
Seoul National University Hospital
Seoul Boramae Medical Center
Gangnam Severance Hospital, Yonsei University
LabGenomics
SCL Clinic (Seoul Clinical Laboratories)
EONE Laboratories
Type Hospital
Referral testing Konkuk University Medical Center
Kyungpook National University Hospital
Gyeongsang National University Hospital
Gachon University Gil Medical Center
National Cancer Center
Dong-A University Hospital
Pusan National University Hospital
CHA Bundang Medical Center
Samsung Medical Center
Seoul Songdo Hospital
Ajou University Hospital
Yangsan Pusan National University Hospital
Myongji Hospital
Jeju National University Hospital
Jeju Halla General Hospital
Chungbuk National University Hospital
Chilgok Kyungpook National University Hospital
Korea Cancer Center Hospital
Hallym University Dongtan Sacred Heart Hospital
Hallym University Sacred Heart Hospital
Chonnam National University Hwasun Hospital
HyoSan Medical Foundation G-SAM Hospital

AlphaLiquid®100 Testing Recommended?

  • · For tumor profiling and treatment selection when tumor tissue is difficult to obtain
  • · During treatment for real time therapy response monitoring
  • · During or after treatment to monitor the emerging resistance mutations

Test Process

  • 01. Consultation on testing
    01.

    Consultation on testing

  • 02. Blood collection
    02.

    Blood collection

  • 03. AlphaLiquid®100 testing
    03.

    AlphaLiquid®100 testing

  • 04. Review of clinical report by treating physician
    04.

    Review of clinical report by treating physician